JP2021530513A5 - - Google Patents

Info

Publication number
JP2021530513A5
JP2021530513A5 JP2021502436A JP2021502436A JP2021530513A5 JP 2021530513 A5 JP2021530513 A5 JP 2021530513A5 JP 2021502436 A JP2021502436 A JP 2021502436A JP 2021502436 A JP2021502436 A JP 2021502436A JP 2021530513 A5 JP2021530513 A5 JP 2021530513A5
Authority
JP
Japan
Prior art keywords
oxazepan
carboxamide
ethyl
cyano
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021502436A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021530513A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/042026 external-priority patent/WO2020018551A1/en
Publication of JP2021530513A publication Critical patent/JP2021530513A/ja
Publication of JP2021530513A5 publication Critical patent/JP2021530513A5/ja
Pending legal-status Critical Current

Links

JP2021502436A 2018-07-17 2019-07-16 炎症性腸疾患を処置するための特定の(2s)−n−[(1s)−1−シアノ−2−フェニルエチル]−1,4−オキサゼパン−2−カルボキサミド Pending JP2021530513A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862699491P 2018-07-17 2018-07-17
US62/699,491 2018-07-17
PCT/US2019/042026 WO2020018551A1 (en) 2018-07-17 2019-07-16 Certain (2s)- n-[(1s)-1-cyano-2-phenylethyl]-1,4- oxazepane-2-carboxamides for treating inflammatory bowel disease

Publications (2)

Publication Number Publication Date
JP2021530513A JP2021530513A (ja) 2021-11-11
JP2021530513A5 true JP2021530513A5 (cg-RX-API-DMAC7.html) 2022-07-21

Family

ID=69163563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021502436A Pending JP2021530513A (ja) 2018-07-17 2019-07-16 炎症性腸疾患を処置するための特定の(2s)−n−[(1s)−1−シアノ−2−フェニルエチル]−1,4−オキサゼパン−2−カルボキサミド

Country Status (7)

Country Link
US (1) US20210252015A1 (cg-RX-API-DMAC7.html)
EP (1) EP3823628A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021530513A (cg-RX-API-DMAC7.html)
KR (1) KR20210032439A (cg-RX-API-DMAC7.html)
AU (1) AU2019305565A1 (cg-RX-API-DMAC7.html)
CA (1) CA3106270A1 (cg-RX-API-DMAC7.html)
WO (1) WO2020018551A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2699580T3 (cg-RX-API-DMAC7.html) 2014-01-24 2018-02-24
PT3758708T (pt) 2018-03-01 2025-02-13 Astrazeneca Ab Composições farmacêuticas compreendendo (2s)-{(1,s)-1-ciano-2-[4-(3-metil-2-oxo-2,3-di-hidro-1,3-benzoxazol-5-il)fenil]etil}-1,4-oxazepano-2-carboxamida
CA3106269A1 (en) 2018-07-17 2020-01-23 Insmed Incorporated Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating lupus nephritis
CN114106005B (zh) * 2020-08-26 2025-08-01 西藏海思科制药有限公司 一种作为二肽基肽酶1抑制剂的腈衍生物及其用途
WO2022140516A1 (en) * 2020-12-22 2022-06-30 Insmed Incorporated Certain (25)-iv-[(ls')~ i-c yan0-2-phenylethyl·]- 1,4-oxazepane-2- carboxamides for treating behcet's disease
WO2022166721A1 (zh) * 2021-02-05 2022-08-11 南京明德新药研发有限公司 含1,4-氧杂氮杂环庚烷的并环类衍生物
US20250101011A1 (en) * 2022-01-11 2025-03-27 Shanghai Yidian Pharmaceutical Technology Development Co., Ltd Peptidyl nitrile compound and use thereof
TW202404960A (zh) * 2022-06-07 2024-02-01 大陸商瑞石生物醫藥有限公司 苯并[c]色滿化合物的多晶型及其製備方法和用途
JP2026503035A (ja) 2023-01-06 2026-01-27 インスメッド インコーポレイテッド 新規な可逆性dpp1阻害剤及びその用途
AU2024237520A1 (en) * 2023-03-16 2025-09-11 Insmed Incorporated Dpp1 inhibitors with polycyclic linkers and uses thereof
WO2025162472A1 (en) 2024-01-31 2025-08-07 Insmed Incorporated Linear dipeptidyl peptidase 1 inhibitors and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110236367A1 (en) * 2000-09-08 2011-09-29 Telenav, Inc. Rat cathespin dipeptidyl peptidase i (dppi): crystal structure and its uses
WO2004106289A1 (en) * 2003-05-30 2004-12-09 Prozymex A/S Protease inhibitors
EP1745292A2 (en) * 2004-04-28 2007-01-24 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with dipeptidyl-peptidase 1 (dpp1)
EA201190235A1 (ru) * 2009-05-07 2012-05-30 Астразенека Аб Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
NO2699580T3 (cg-RX-API-DMAC7.html) * 2014-01-24 2018-02-24
WO2018022978A1 (en) * 2016-07-29 2018-02-01 Insmed Incorporated Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiectasis
EP3749326A4 (en) * 2018-02-07 2021-11-03 Insmed Incorporated CERTAIN (2S) -N - [(1S) -1-CYANO-2-PHENYLETHYL] -1,4-OXAZEPAN-2-CARBOXAMIDE FOR THE TREATMENT OF VASCULITIDES ASSOCIATED WITH ANCA

Similar Documents

Publication Publication Date Title
JP2022096662A5 (cg-RX-API-DMAC7.html)
JP2021512904A5 (cg-RX-API-DMAC7.html)
JP2023156479A5 (cg-RX-API-DMAC7.html)
JP2022166188A5 (cg-RX-API-DMAC7.html)
RU2472509C2 (ru) Способ лечения артрита
JP2021530525A5 (cg-RX-API-DMAC7.html)
JP2023536462A5 (cg-RX-API-DMAC7.html)
EP3823628A1 (en) <smallcaps/>? ? ?s? ? ? ? ?certain (2)- <ns1:i>n</ns1:i>?-[(1 <ns2:i>s</ns2:i>?)-1-cyano-2-phenylethyl]-1,4- oxazepane-2-carboxamides for treating inflammatory bowel disease
JP2015526458A5 (cg-RX-API-DMAC7.html)
KR20190109590A (ko) 선택적인 bcl­2 억제제를 사용하는 치료 방법
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2013523746A5 (cg-RX-API-DMAC7.html)
JP2024516826A5 (cg-RX-API-DMAC7.html)
WO2023049886A1 (en) Imidazopyridazine il-17 inhibitor compounds
JP2008534453A5 (cg-RX-API-DMAC7.html)
EP2455080A1 (en) S1P1 receptor agonists for use in the treatment of multiple sclerosis
RU2009148507A (ru) Производное тетрагидроизохинолин-1-она или его соль
TW201912153A (zh) 用於治療b型肝炎的化合物、醫藥組合物及方法
JP2025508359A5 (cg-RX-API-DMAC7.html)
JP2024095711A (ja) 可溶性グアニル酸シクラーゼ活性化薬としてのアルコキシピラゾール
WO2021201201A1 (ja) 新型コロナウイルス感染症(covid-19)の予防または治療剤および医薬組成物
RU2009135255A (ru) Производные индола
JP2021531308A5 (cg-RX-API-DMAC7.html)
JP2021519285A5 (cg-RX-API-DMAC7.html)
RU2011121511A (ru) Гетероциклические антивирусные производные арилпиридона